(Q58409657)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

editorial

0 references

title

Surrogate markers of response to cancer immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

M A Morse

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

T M Clay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A C Hobeika

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

P J Mosca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

153-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Quantification of antigen specific CD8+ T cells using an ELISPOT assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interkukin-2 in peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.153

21 January 2018

Identifiers

DOI

10.1517/14712598.1.2.153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11727526%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference